期刊文献+

乳腺癌组织Cox-2和VEGF表达及与激素受体关系的研究 被引量:4

Relationship between hormone receptor and the expressions of cyclooxygenase-2 and VEGF in breast cancer
下载PDF
导出
摘要 目的:研究环氧化酶-2(Cox-2)及血管内皮细胞生长因子(VEGF)在乳腺癌发生发展中的相关作用。方法:应用免疫组织化学法检测128例乳腺癌组织中Cox-2、VEGF及ER和PR的表达。结果:Cox-2及VEGF在乳腺癌组织中的表达有明显正相关(rs=0.852,P<0.05),并且在激素受体阴性组患者的表达高于阳性组患者,(χ2cox-2=12.40,χ2VEGF=8.85,P<0.01)。结论:Cox-2及VEGF在乳腺癌的表达具有提示预后的作用,其相应抑制剂有一定的临床应用前景。 OBJECTIVE: To investigate the expressions of cyclooxygenase-2 ( Cox-2 ) and vascular endothelial growth factor (VEGF) in human breast cancer and their correlation. METHODS: Expressions of Cox-2 and VEGF including ER and PR in 128 cases of human breast cancer were detected with immunohistochemistry. RESULTS: The expressions of Cox-2 and VEGF in breast cancer had a close relation,r1 = 0. 852, P〈0. 05. The positive rates of Cox-2 and VEGF were significantly higher in positive hormane receptor tumor than those in negative ones (χcox-2^2 = 12.40, χVEGF^2 = 8.85 , P〈0.01). CONCLUSIONS: The expressions of Cox-2 and VEGF may play an important role of prognosis of breast cancer. Selective Cox-2 and VEGF inhihitors may he useful in the chemoprevention and therapy of human breast cancer.
出处 《中华肿瘤防治杂志》 CAS 2008年第10期762-764,共3页 Chinese Journal of Cancer Prevention and Treatment
关键词 乳腺肿瘤 血管内皮生长因子A 前列腺素内过氧化物合酶 激素受体 breast neoplasms vascular endothelial growth factor A prostaglandin-endoperoxide synthase hormane receptor
  • 相关文献

参考文献9

  • 1Denkert C,Winzer K J,Muller B M,et al.Elevated expression of cyclooxy genase-2 is a hagative prognostic factor for disease free survival and overall survival in patients with breast carcinoma[J].Cancer,2008,97(12):2978-2987.
  • 2刘鹏,孙慧,宁连胜,战忠利.血管内皮生长因子与乳腺癌临床病理因素及预后的关系[J].天津医科大学学报,2002,8(2):144-146. 被引量:18
  • 3Moran E M.Epidem iological and clinical aspect of nonsteroidal anti inflammatory drags and cancer risks[J].J Environ Pathol Toxical Oncol,2002,21(2):193-201.
  • 4Ali-Fehmi R,Morris RT,Bandyopadhyay S,et al.Expression of cyclooxygenase-2 in advanced stage ovarian serous carcinoma:Correlation with tumor cell proliferation,apoptosis,angiogenesis,and survival[J].Am J Obstet Gynecol,2005,192(3):819-825.
  • 5Singh-Ranger G,Mokbel K.American society of clinical oncology[J].Curr Med Res Opin,2002,18(7):401-406.
  • 6Zhang D H,Salto-Tellez M,Chiu L L,et al.Tissue microarray study for classification of breast tumors[J].Life Sci,2003,73(25):3189-3199.
  • 7刘风军,鹿伟,孙德刚,成玉霞,孙青.乳腺癌组织微阵列HER-2和COX-2的表达及其相关性研究[J].中华肿瘤防治杂志,2006,13(17):1317-1320. 被引量:3
  • 8Zellars R C,Hilsenbeck S G,Clark G M,et al.Prognostic Value of P53 for local failure in mastectomy-treated breast cancer patients[J].J clin Oncol,2000,18(9):1906-1913.
  • 9Diaz-Cruz E S,Shapiro C L,Brueggemeier R W.Cyclooxygenase inhibitors suppress arom atase expression and activity in breast carcinoma cells[J].J Clin Endocrinol Metab,2005,90(5):2563-2570.

二级参考文献12

  • 1Parkin D M,Fernandez L M.Use of statistics to assess the global burden of breast cancer[J].Breast J,2006,12 Suppl 1:70-80.
  • 2Moch H,Kononen T,Kallionie mi O P,et al.Tissue microarrays:What will they bring to molecular and anatomic pathology?[J].Adv Anathol,2001,8(1):14-20.
  • 3Press M F,Sauter G,Bernstein L,et al.Diagnostic evaluation of HER-2 as a molecular target:an assessment of accuracy and reproducibility of laboratory testing in large,prospective,randomized clinical trials[J].Clin Cancer Res,2005,11(18):6598-6607.
  • 4Jukkola A,Bloigu R,Soini Y,et al.C-erbB-2 positively is a factor for poor prognosis in breast cancer and poor response to hormonal or chemotherapy treatment in advanced disease[J].Eur J Cancer,2001,37(3):347-354.
  • 5Soslow R A,Dannenberg A J,Rush D,et al.COX-2 is expressed in human pulmonary,colonic,and mammary tumors[J].Cancer,2000,89(12):2637-2645.
  • 6Bamba H,Ota S,Kato A,et al.Prostaglandins up-regulate vascular endothelial growth factoe production distict pathways in differentiated U 937 cells[J].Biochem Biophys Res Commun,2000,273(2):487-491.
  • 7Ristimaki A,Sivula A,Lundin J,et al.Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer[J].Cancer Res,2002,62(3):632-635.
  • 8Harris R E,Alshafie G A,Abou Issa H,et al.Chemoprevention of breast cancer in rats by celecoxib,a cyxlooxygenase 2 inhibitor[J].Cancer Res,2000,60(8):2101-2103.
  • 9Lanza-Jacoby S,Miller S,Flynn J,et al.The cyclooxygenase-2 inhibitor,celecoxib,prevents the development of mammary tumors in Her-2/neu mice[J].Cancer Epidemiol Biomarkers Prev,2003,12(12):1486-1491.
  • 10Benoit V,Relic B,Leval-Xd X,et al.Regulation of HER-2 oncogene expression by cyclooxygenase-2 and prostaglandin E2[J].Oncogene,2004,23(8):1631-1635.

共引文献19

同被引文献37

  • 1刘运江,吴凤云,刘巍,吴祥德.乳腺癌骨髓微转移状况与ER PR VEGF及Cath-D等因子的关系[J].中国肿瘤临床,2004,31(20):1178-1181. 被引量:5
  • 2康华峰,王西京,刘小旭,代志军,薛锋杰,薛兴欢.塞来昔布预防大鼠乳腺癌发生及其机制[J].南方医科大学学报,2006,26(11):1599-1602. 被引量:9
  • 3Shimizu H,Ross RK,Bernstein L,et al.Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County[J].Br J Cancer,1991,63(6):963-966.
  • 4Jiang WG,Douglas-Jones AG,Mansel RE.Aberrant expression of 5-1ipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer[J].Prostaglandins Leukot Essent Fatty Acids,2006,74(2):125-134.
  • 5Sudb? J,Ristim?ki A,Sondresen JE,et all.Cyclcoxygenase-2 (COX-2) expression in high-risk premalignant oral lesions[J].Oral Oncol,2003,39(5):497-505.
  • 6Tomozawa S,Tsuno NH,Sunami E,et al.Cyclooxygenase-2 overexpression correlates with tumour recurrence,especially haematogenous metastasis,of colorectal cancer[J].Br J Cancer,2000,83(3):324-328.
  • 7Soslow RA,Dannenberg AJ,Rush D,et al.COX-2 is expressed in human pulmonary,colonic,and mammary tumors[J].Cancer,2000,89(12):2637-2645.
  • 8Ding XZ,Iversen P,Cluck MW,et al.Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells[J].Biochem Biophys Res Commun,1999,261 (1):218-223.
  • 9Romano M,Catalano A,Nutini M,et al.Procopio A.5-lipoxygenase regulates malignant mesothelial cell survival:involvement of vascular endothelial growth factor[J].FASEB J,2001,15 (13):2326-2336.
  • 10Sliwkowski MX,Lofgren JA,Lewis GD,et al.Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin)[J].Semin 0ncol,1999,26(4 Suppl 12):60-70.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部